Biotech Rakovina Therapeutics and Variational AI Advance Brain-Penetrant ATR Program Toward Development Candidate Selection October 22, 2026
Biotech Pharming Group announces third quarter 2026 revenues above market expectations October 21, 2026
Biotech argenx Reports Third Quarter 2026 Financial Results and Provides Business Update October 21, 2026
Biotech Oculis Reports New Phase 2 ACUITY Biomarker Data Further Supporting Privosegtor’s Neuroprotective Potential in Optic Neuritis October 21, 2026
Biotech Quoin Pharmaceuticals Announces Publication of Peer-Reviewed Paper on QRX003 for Netherton Syndrome in Dermatology and Therapy October 20, 2026
Biotech Rapport Therapeutics Announces Positive Topline Results from its Phase 2 Trial of RAP-219 for the Treatment of Bipolar Mania October 20, 2026
Biotech Alvotech receives FDA approval for new SIMLANDI® manufacturing process that more than doubles output per batch October 20, 2026
Biotech Oculis to Present Late-Breaking Phase 2 ACUITY Biomarker Analyses of Privosegtor in Optic Neuritis at the 10th Joint ACTRIMS-ECTRIMS Meeting October 19, 2026
Biotech CUMBERLAND PHARMACEUTICALS ANNOUNCES NATIONAL CALL TO PRESENT AN UPDATE ON ITS IFETROBAN DMD PROGRAM October 19, 2026
Biotech Jazz Pharmaceuticals to Report Third Quarter Financial Results on November 2, 2026 October 19, 2026
Search
Biotech
October 22, 2026
October 21, 2026
October 21, 2026
October 21, 2026
October 20, 2026
October 20, 2026
October 20, 2026
October 19, 2026
October 19, 2026
October 19, 2026
